ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Overcoming The Challenges Of Fragmented Supply Chains

  As trials grow more complex, managing clinical supplies is increasingly challenging. In this webinar, experts discussed GxP inventory management and integrated solutions to overcome these hurdles.

• Developmental Testing Of IV Solutions

  As IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration.

• Understanding Injectable Drug Container Closure Systems

  Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

• Enhancing Clinical Supply Chain With Signant SmartSignals Supplies

  A global pharma leader improved supply chain efficiency and compliance by digitalizing processes with Signant's SmartSignals Supplies, achieving better visibility, traceability, and reduced errors.

• Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply Chain

  With many BREXIT provisions now in effect and more to come, supply chains serving clinical trials in the UK and/or EU member states must navigate a complex web of new regulations.

• How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain

  In an increasingly competitive and regulated landscape, the right ERP system is no longer optional—it’s essential to reclaim control and drive growth in pharmaceutical manufacturing.

• Key Considerations For Emerging Companies When Selecting Packaging Components

  Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.

• Outsourcing Your Highly Potent Oncology Drug Product

  Precision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.

• RTSM Manages Clinical IP Dispensation In Schizophrenia Study

  Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.

• My Worst Nightmare In RSTM: Accidental Unblinding

  Learn how collaborative efforts from study managers, supply managers, biostatisticians, designers, and clinicians can better protect the blind in clinical trials and prevent accidental unblinding.